Investment in Potential

2023-10-27T14:53:06+01:00

Cinclus Pharma

Cinclus Pharma is a Swedish clinical-stage pharma company developing small molecules for the treatment of gastric acid-related diseases. Our lead candidate linaprazan glurate is being developed for the treatment of moderate to severe gastroesophageal reflux disease (GERD).

2023-10-27T15:15:48+01:00

DermView

DermView’s technology enables patients, hospitals and clinics to receive rapid, accurate diagnosis from leading Mohs1 surgeons, consultant dermatologists and plastic surgeons. It provides Ireland’s fastest route to access a Consultant Dermatologist diagnosis.

2023-10-27T15:18:48+01:00

Ovagen

Ovagen is a biotechnology company that has developed a proprietary process of producing Germ Free chicken eggs and Germ Free birds in commercial quantities for use primarily in the vaccine and pharmaceutical industry.

2023-10-27T15:19:39+01:00

Gasgon Medical

Gasgon Medical is an award winning start-up medical device company, based in Cork, Ireland, developing innovative fluid management products for the clinical market, including AirVault™, a single-use device to remove air bubbles from IV fluids.

2021-05-06T10:14:53+01:00

Aruna Bio

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders.

2021-05-06T10:19:53+01:00

AniV8

AniV8 (pronounced An-i-vate) is a company designed to become the leading developer of clinical sensor technology recommended by veterinarians to diagnose and monitor common animal disease states.

2021-05-06T10:22:13+01:00

Qualus

Qualus helps tanneries save costs, lower their environmental footprint and improve quality in leather production through the use of their patented technology, which uses polymer sferes to more effectively deliver chemicals into hides.

2021-05-06T10:23:53+01:00

Sedana Medical

Sedana medical, a Swedish company, are the developers of the AnaConDa (Anaesthetic Conserving Device) which is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as Isoflurane or Sevoflurane to invasively ventilated patients.

2021-05-06T10:25:42+01:00

Mirai Medical

Developer of medical devices designed to improve the outcome of cancer treatment. The company's technology has a unique IP that facilitates for painless delivery of electroporation energy endoscopically which greatly facilitates cancer treatment, enabling physicians to target tumors located anywhere on the body.

If you are interested in becoming an Investor or seeking investment, then please contact us.